Nirsevimab Lowers RSV Hospitalizations More Than Maternal Vaccination: JAMA Dr Riya Dave19 Jan 2026 8:45 PM ISTAccording to a new study, respiratory syncytial virus (RSV) is a major contributor to infant admissions into the hospital. The comparative...
Nirsevimab Reduces RSV and Other LRTI-Related Hospitalizations in Infants: JAMA Medha Baranwal30 Dec 2025 11:30 PM ISTCanada: A meta-analysis published in JAMA Pediatrics has revealed that nirsevimab (Beyfortus) not only reduces RSV-related hospitalizations and...
New tool may help identify infants at high risk for poor RSV outcomes, reveals study Dr. Kamal Kant Kohli24 May 2024 7:30 AM ISTOn the heels of a shortage of nirsevimab for infant respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) prevention, a new tool...
